AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Roche Diagnostics at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Roche Diagnostics brings 5 presentations to AMP 2026 in Seattle, and exhibits at Booth 700. Its sessions centre on automated sequencing workflows, from a lyophilization-ready preparation and amplification chain to sequencing on the AXELIOS 1 platform and integrated profiling of blood cancers. Others cover phenotype-driven whole-exome sequencing for variant or fusion detection and HLA class I typing from comprehensive genomic profiling.
| Organization | AMP 2026 Attendance |
|---|---|
Roche Diagnostics Indianapolis, IN | |
Clinical diagnostics, life science research, digital PCR and next-generation sequencing systems and assays for laboratories. | Booth Exhibiting at Booth 700 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Diamond Partner Workshop Wed, Nov 11 10:00am–10:50am Unlocking the Complete Lyo-Ready Workflow: From Sample Preparation to Amplification A shelf-stable reagent set spanning sample prep, reverse transcription and amplification for assays built without cold-chain storage. Workshop Wed, Nov 11 11:00am–11:50am Automated and Integrated Genomic Profiling of Hematologic Malignancies Sequencing workflows for blood cancers that report mutations, structural variants and clonal evolution in one automated run. Workshop Wed, Nov 11 12:00pm–12:50pm Next-Generation Sequencing with Roche’s AXELIOS 1 Platform Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility. Workshop Wed, Nov 11 1:00pm–1:50pm Versatile Whole-exome Sequencing Enables End-to-end Phenotype-driven DNA-variant identification or RNA-fusion detection Phenotype-driven exome workflows for germline variant discovery, plus two RNA-sequencing routes to fusions. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. |
Find decision makers at Roche Diagnostics
Tell us what you sell and we’ll find the people at Roche Diagnostics most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction